Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Annovis Bio, Inc. (ANVS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Operating expenses:          
Research and development  22.918.713.114.410.48.28.57.0
General and administrative  7.68.19.010.49.68.36.13.5
    Total operating expenses  30.626.822.124.820.016.614.510.5
    Operating loss  -30.6-26.8-22.1-24.8-20.0-16.6-14.5-10.5
   
Other income:          
Interest income, net  0.60.40.20.10.10.00.00.0
    Total other income  0.60.40.20.10.10.00.10.2
    Loss before income taxes  -44.6-41.0-36.5 -25.7-22.2-20.2 
    Net loss  -30.0-26.4-21.9-24.7-19.9-16.5-14.5-10.3
   
Basic loss per common share  ($3.57)($3.23)($2.68)($3.05)($2.47)($2.08)($1.90)($1.41)
Diluted loss per common share  ($3.57)($3.23)($2.68)($3.05)($2.47)($2.08)($1.90)($1.41)
   
Weighted average number of common shares outstanding, basic  8.48.28.28.08.07.87.57.2
Weighted average number of common shares outstanding, diluted  8.48.28.28.08.07.87.57.2

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy